» Articles » PMID: 23340690

Interactions of Disulfide-constrained Cyclic Tetrapeptides with Cu(2+)

Overview
Publisher Springer
Specialty Biochemistry
Date 2013 Jan 24
PMID 23340690
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this work is to characterize the interactions of two disulfide-constrained cyclic tetrapeptides [c(Ac-Cys-Pro-Phe-Cys-NH(2)), SS1; c(Ac-Cys-Pro-Gly-Cys-NH(2)), SS2] with Cu(2+) ions in order to facilitate the design of cyclic peptides as sensors for metal ions. The Cu(2+)-peptide complex cations at m/z 569.1315 for Cu(2+)-SS1 and m/z 479.0815 for Cu(2+)-SS2 were detected by mass spectrometry. The gas-phase fragmentation of the Cu(2+)-peptide complexes was studied by collision-induced dissociation and suggests the atoms involved in the coordination. Cu(2+) ion binds to a single SS1 or SS2 with K (d(app)) of 0.57 ± 0.02 and 0.55 ± 0.01 μM, respectively. Isothermal titration calorimetry data indicate both enthalpic and entropic contributions for the binding of Cu(2+) ion to SS1 and SS2. The characteristic wavenumber of 947 cm(-1) and the changes at 1,664 and 1,530 cm(-1) in the infrared spectrum suggest that the sulfydryl of cysteine, the carbonyl group, and amide II are involved in the coordination of Cu(2+). The X-ray absorption near-edge structure signal from the Cu(2+)-peptide complex corresponds to the four-coordination structure. The extended X-ray absorption fine structure and electron paramagnetic resonance results demonstrate the Cu(2+) ion is in an S/N/2O coordination environment, and is a distinct type II copper center. Theoretical calculations further demonstrate that Cu(2+) ion binds to SS1 or SS2 in a slightly distorted tetragonal geometry with an S/N/2O environment and the minimum potential energy.

References
1.
Liehr S, Barbosa J, Smith 3rd A, Cooperman B . Synthesis and biological activity of cyclic peptide inhibitors of ribonucleotide reductase. Org Lett. 2000; 1(8):1201-4. DOI: 10.1021/ol9909381. View

2.
Tamilarasu N, Huq I, Rana T . Design, synthesis, and biological activity of a cyclic peptide: an inhibitor of HIV-1 tat-TAR interactions in human cells. Bioorg Med Chem Lett. 2000; 10(9):971-4. DOI: 10.1016/s0960-894x(00)00140-2. View

3.
Jelokhani-Niaraki M, Kondejewski L, Wheaton L, Hodges R . Effect of ring size on conformation and biological activity of cyclic cationic antimicrobial peptides. J Med Chem. 2009; 52(7):2090-7. PMC: 2759687. DOI: 10.1021/jm801648n. View

4.
Hashizume H, Adachi H, Igarashi M, Nishimura Y, Akamatsu Y . Biological activities of pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp. J Antibiot (Tokyo). 2010; 63(6):279-83. DOI: 10.1038/ja.2010.29. View

5.
Wyttenbach T, Liu D, Bowers M . Interactions of the hormone oxytocin with divalent metal ions. J Am Chem Soc. 2008; 130(18):5993-6000. DOI: 10.1021/ja8002342. View